Insider · CIK 0002089237
Phillip Andrew Dennis
Files at NBP (NovaBridge Biosciences). First filing Jun 22, 2026, latest Sep 21, 2026.
Phillip Andrew Dennis files SEC Form 4 as officer at NBP (NovaBridge Biosciences). Since Jun 22, 2026, Phillip Andrew Dennis has reported 0 open-market buys worth $0 and 2 open-market sells worth $11k, the latest filed on Sep 21, 2026.
A track record needs three past buys with six months of prices behind them; Phillip Andrew Dennis has 0, so none is measured yet.
The newest scored trade: sold $5,828 of NBP on Sep 18, 2026, filed Sep 21, 2026, scored 8 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $11k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NBP: NovaBridge Biosciences
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | NovaBridge Biosciences | $5,828 8,209 shares | -5% | - | |
| 0Weak | NBPsell NovaBridge Biosciences | $5,606 8,494 shares | -5% | +2% from low-77% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 18, 2026 | NBP NovaBridge Biosciences | 3,569 0.00% of outstanding | $5,799 | Sep 18, 2026 | $5,593 |
| Mar 18, 2026 | NBP NovaBridge Biosciences | 3,638 0.00% of outstanding | $10k | Mar 18, 2026 | $15k |
| Dec 18, 2025 | NBP NovaBridge Biosciences | 3,431 0.00% of outstanding | $15k | Dec 18, 2025 | $12k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | NBP NovaBridge Biosciences | MOption exercise Ordinary Shares | +23,695 | - | - | 181,636 | 22 d ago |
| Sep 18, 2026 | NBP NovaBridge Biosciences | SOpen-market sale Ordinary Shares | -8,209 | $0.71 | $5,828 | 173,427 | 22 d ago |
| Sep 17, 2026 | NBP NovaBridge Biosciences | MOption exercise Restricted Share Unitsderivative | -10,302 | $0.00 | $0 | 72,120 | 22 d ago |
| Jun 17, 2026 | NBP NovaBridge Biosciences | MOption exercise Ordinary Shares | +23,695 | - | - | 166,435 | Jun 22, 2026 |
| Jun 18, 2026 | NBP NovaBridge Biosciences | SOpen-market sale Ordinary Shares | -8,494 | $0.66 | $5,606 | 157,941 | Jun 22, 2026 |
| Jun 17, 2026 | NBP NovaBridge Biosciences | MOption exercise Restricted Share Unitsderivative | -10,302 | $0.00 | $0 | 82,422 | Jun 22, 2026 |
Questions about Phillip Andrew Dennis
Answered from the filings on this page, as of the latest one.
Is Phillip Andrew Dennis buying or selling?
In the last 12 months Phillip Andrew Dennis reported 0 open-market buys worth $0 and 2 open-market sells worth $11k on SEC Form 4; the latest was sold $5,828 of NBP on Sep 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Phillip Andrew Dennis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Phillip Andrew Dennis has 0.
Where does Phillip Andrew Dennis file Form 4?
Phillip Andrew Dennis has filed Form 4 at NBP (NovaBridge Biosciences) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.